Abstract
Nitric oxide (NO) is a potent regulator of keratinocyte growth and differentiation that has been implicated in the pathogenesis of psoriasis (Ps). The NOS3 −786 T/C (SNP id rs2070744; http://www.ensembl.org), intron 4 variable number tandem repeat (VNTR), and Glu298Asp (SNP id rs1799983) polymorphisms, have been associated with differences in NO plasma concentrations and with the risk of hypertension (HT) and ischemic cardiac disease. The aim of this study was to determine whether the above-mentioned NOS3 variants contributed to the risk of Ps, and were associated with the risk for HT and CAD in these patients. A total of 368 patients with chronic plaque Ps and 400 healthy controls were genotyped for the NOS3 −786 T/C, intron 4 VNTR, and Glu298Asp polymorphisms. Carriers of the −786 C allele were significantly more frequent among the patients (p < 0.001). Carriers of the 4-repeats allele (45 + 44 genotypes) were also more frequent a (p < 0.001). No significant difference was found for the Glu298Asp polymorphism. None of the NOS3 variants was associated with Ht and CAD in our population. In conclusion, NOS3 gene polymorphism would be risk factors for developing Ps.
References
Abeyakirthi S, Mowbray M, Bredenkamp N, van Overloop L, Declercq L, Davis PJ et al (2010) Arginase is overactive in psoriatic skin. Br J Dermatol 163:193–196
Álvarez R, González P, Batalla A, Reguero JR, Iglesias-Cubero G, Hevia S et al (2001) Association between the NOS3 (−786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 5:343–348
Bruch-Gerharz D, Schnorr O, Suschek C, Beck KF, Pfeilschifter J, Ruzicka T, Kolb-Bachofen V (2003) Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol 162:203–211
Cals-Gierson MM, Ormerod AD (2004) Nitric oxide function in the skin. Nitric Oxide 10:179–193
Christophers E (2001) Psoriasis—epidemiology and clinical spectrum. Clin Exp Dermatol 26:314–320
Doshi AA, Ziolo MT, Wang H, Burke E, Lesinski A, Binkley P (2010) A promoter polymorphism of the endothelial nitric oxide synthase gene is associated with reduced mRNA and protein expression in failing human myocardium. J Card Fail 16:314–319
García-Diez A, Foraster CF, Sebastián FV, Tudela LL, Llach XB, Fernández GS (2008) What characterizes the severity of psoriasis? Results from an epidemiological study of over 3,300 patients in the Iberian region. Dermatology 216:137–151
Gisondi P, Tessari A, Conti A, Piaserico S, Schianchi S, Peserico A et al (2007) Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case–control study. Br J Dermatol 157:68–73
Gokhale NR, Belgaumkar VA, Pandit DP, Deshpande S, Damle DK (2005) A study of serum nitric oxide levels in psoriasis. Indian J Dermatol Venereol Leprol 71(3):175–178
Jackson M, Frame F, Weller R, McKenzie RC (1998) Expression of nitric oxide synthase III (eNOS) mRNA by human skin cells: melanocytes but not keratinocytes express eNOS mRNA. Arch Dermatol Res 290:350–352
Kolb-Bachofen V, Fehsel K, Michel G, Ruzicka T (1994) Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet 344:139
Lee CR, North KE, Bray MS, Avery CL, Mosher MJ, Couper DJ (2006) NOS3 polymorphisms, cigarette smoking, and cardiovascular disease risk: the Atherosclerosis Risk in Communities Study. Pharmacogenet Genomics 16(12):891–899
Mallbris L, Akre O, Granath F, Yin L, Lindelof B, Ekbom A et al (2004) Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 19:225–230
Metzger IF, Sertório JT, Tanus-Santos JE (2007) Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes. Free Radic Biol Med; 43:987–992
Moll JMH, Wright V (1973) Psoriatic arthritis. Semin Arthritis Rheum 3:55–78
Moncada S, Higgs A (1993) The l-arginine–nitric oxide pathway. N Engl J Med 329:2002–2012
Morhenn VB (1997) Langerhans cells may trigger the psoriatic disease process via production of nitric oxide. Immunol Today 18:433–436
Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H et al (1999) T-786–>C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99:2864–2870
Namazi MR (2003) A complementary note on the Morhenn’s hypothesis on the pathomechanism of psoriasis. Immunol Lett 85:223
Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM (2006) Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 55:829–835
Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496–509
Ormerod AD, Weller R, Copeland P, Benjamin N, Ralston SH, Grabowski P et al (1998) Detection of nitric oxide and nitric oxide synthases in psoriasis. Arch Dermatol Res 290:3–8
Ormerod AD (2000) Treatment of psoriasis with topical NG monomethyl-l-arginine, an inhibitor of nitric oxide synthesis. Br J Dermatol 145:985–986
Orem A, Aliyazicioglu R, Kiran E, Vanizor B, Cimnocodeit G, Deger O (1997) The relationship between nitric oxide production and activity of the disease in patients with psoriasis. Arch Dermatol 133:1606–1607
Rowe A, Farrell AM, Bunker CB (1997) Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 136:18–23
Senturk N, Kara N, Aydin F, Gunes S, Yuksel EP, Canturk T et al (2006) Association of eNOS gene polymorphism (Glu298Asp) with psoriasis. J Dermatol Sci 44(1):52–55
Sirsjo A, Karlsson M, Gidlof A, Rollman O, Torma H (1996) Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured keratinocytes. Br J Dermatol 134:643–648
Tekin NS, Ilter N, Sancak B, Ozden MG, Gurer MA (2006) Nitric oxide levels in patients with psoriasis treated with methotrexate. Mediat Inflamm 3:1–5
Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A et al (1998) Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 245:190–193
Weller R, Ormerod A (1997) Increased expression of inducible nitric oxide (NO) synthase. Br J Dermatol 136:136–137
Zhang MX, Zhang C, Shen YH, Wang J, Li XN, Zhang Y et al (2008) Biogenesis of short intronic repeat 27-nucleotide small RNA from endothelial nitric-oxide synthase gene. J Biol Chem 283:14685–14693
Zhang MX, Zhang C, Shen YH, Wang J, Li XN, Chen L et al (2008) Effect of 27nt small RNA on endothelial nitric-oxide synthase expression. Mol Biol Cell 19:3997–4005
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Coto-Segura, P., Coto, E., Mas-Vidal, A. et al. Influence of endothelial nitric oxide synthase polymorphisms in psoriasis risk. Arch Dermatol Res 303, 445–449 (2011). https://doi.org/10.1007/s00403-011-1129-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-011-1129-9